Camarda Financial Advisors’s Medtronic MDT Stock Holding History

Camarda Financial Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-40	Closed	-$3K	–	250
2017 Q1	$3K	Sell	40 -589	-94%	-$46K	﹤0.01%	160
2016 Q4	$45K	Buy	629 +589	+1,473%	+$46.3K	0.03%	126
2016 Q3	$3K	Sell	40 -40	-50%	-$3.49K	﹤0.01%	195
2016 Q2	$7K	Hold	80	–	–	﹤0.01%	226
2016 Q1	$6K	Buy	+80	New	+$6.03K	﹤0.01%	212
2015 Q2	–	Sell	-14	Closed	-$1K	–	255
2015 Q1	$1K	Sell	14 -2,173	-99%	-$165K	﹤0.01%	238
2014 Q4	$158K	Sell	2,187 -891	-29%	-$61.9K	0.1%	88
2014 Q3	$191K	Buy	3,078 +891	+41%	+$56.7K	0.13%	86
2014 Q2	$139K	Hold	2,187	–	–	0.1%	92
2014 Q1	$135K	Buy	+2,187	New	+$127K	0.1%	84

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Camarda Financial Advisors's MDT Position: Q2 2017 in Review

Camarda Financial Advisors sold out of Medtronic (MDT) in Q2 2017, closing a stake of 40 shares — an estimated $3K sold.

Camarda Financial Advisors first reported a position in MDT in Q1 2014 and held it in 10 quarters. The position peaked at $191K in Q3 2014. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

Camarda Financial Advisors reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
Camarda Financial Advisors sold 40 Medtronic shares in Q2 2017, an estimated $3K.
Camarda Financial Advisors first reported a position in Medtronic in Q1 2014 and held it in 10 quarters.
Camarda Financial Advisors's Medtronic position peaked at $191K in Q3 2014.
1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Camarda Financial Advisors's 13F filing for Q2 2017, filed 14 Jul 2017.